Phase 3 Study Shows Majority of Neutropenia with Related Fever and Hospitalization Occurs in First Treatment Cycle for Breast Cancer Patients Not Receiving Neulasta Read more about Phase 3 Study Shows Majority of Neutropenia with Related Fever and Hospitalization Occurs in First Treatment Cycle for Breast Cancer Patients Not Receiving Neulasta
Amgen Announces $5 Billion Stock Repurchase Plan Read more about Amgen Announces $5 Billion Stock Repurchase Plan
FDA Grants Fast Track Designation for Amgen's AMG 531 and AMG 706 Experimental Therapies to Potentially Treat Life-Threatening Conditions Read more about FDA Grants Fast Track Designation for Amgen's AMG 531 and AMG 706 Experimental Therapies to Potentially Treat Life-Threatening Conditions
Nominations Open for the Amgen Award For Science Teaching Excellence Read more about Nominations Open for the Amgen Award For Science Teaching Excellence
Nominations Open for the Amgen Award For Science Teaching Excellence; 19 Outstanding Teachers Will Be Recognized in Communities Where Amgen Operates Read more about Nominations Open for the Amgen Award For Science Teaching Excellence; 19 Outstanding Teachers Will Be Recognized in Communities Where Amgen Operates
Published Head-to-Head Data Show Aranesp Dosed Every Two Weeks is Comparable to Epoetin Alfa Dosed Once-a-Week Read more about Published Head-to-Head Data Show Aranesp Dosed Every Two Weeks is Comparable to Epoetin Alfa Dosed Once-a-Week
Amgen Announces Offer of $2 Billion in Two Series of Senior Notes Read more about Amgen Announces Offer of $2 Billion in Two Series of Senior Notes
Amgen Announces the Formation of Amgen Ventures; Venture Capital Fund Designed to Provide Resources to Help Advance Early-Stage Biotechnology Companies and Human Therapeutics Read more about Amgen Announces the Formation of Amgen Ventures; Venture Capital Fund Designed to Provide Resources to Help Advance Early-Stage Biotechnology Companies and Human Therapeutics
European Commission Approves Innovative First-in-Class Treatment for a Serious Complication of Chronic Kidney Disease Read more about European Commission Approves Innovative First-in-Class Treatment for a Serious Complication of Chronic Kidney Disease
Amgen Launches Landmark Trial to Evaluate the Impact of Treating Anemia on Cardiovascular Risks in Patients with Chronic Kidney Disease and Type 2 Diabetes Read more about Amgen Launches Landmark Trial to Evaluate the Impact of Treating Anemia on Cardiovascular Risks in Patients with Chronic Kidney Disease and Type 2 Diabetes
